Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 31
2003 28
2004 24
2005 23
2006 25
2007 27
2008 38
2009 28
2010 37
2011 36
2012 39
2013 30
2014 39
2015 34
2016 30
2017 31
2018 29
2019 43
2020 63
2021 53
2022 36
2023 50
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

690 results

Results by year

Filters applied: . Clear all
Page 1
Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric setting.
Kumbrink J, Demes MC, Jeroch J, Bräuninger A, Hartung K, Gerstenmaier U, Marienfeld R, Hillmer A, Bohn N, Lehning C, Ferch F, Wild P, Gattenlöhner S, Möller P, Klauschen F, Jung A. Kumbrink J, et al. Among authors: moller p. Pathol Oncol Res. 2024 Mar 28;30:1611590. doi: 10.3389/pore.2024.1611590. eCollection 2024. Pathol Oncol Res. 2024. PMID: 38605929 Free PMC article.
Predicting the presence of coronary plaques featuring high-risk characteristics using polygenic risk scores and targeted proteomics in patients with suspected coronary artery disease.
Møller PL, Rohde PD, Dahl JN, Rasmussen LD, Nissen L, Schmidt SE, McGilligan V, Gudbjartsson DF, Stefansson K, Holm H, Bentzon JF, Bøttcher M, Winther S, Nyegaard M. Møller PL, et al. Genome Med. 2024 Mar 20;16(1):40. doi: 10.1186/s13073-024-01313-8. Genome Med. 2024. PMID: 38509622 Free PMC article.
Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid.
Zahm S, Bonde JP, Chiu WA, Hoppin J, Kanno J, Abdallah M, Blystone CR, Calkins MM, Dong GH, Dorman DC, Fry R, Guo H, Haug LS, Hofmann JN, Iwasaki M, Machala M, Mancini FR, Maria-Engler SS, Møller P, Ng JC, Pallardy M, Post GB, Salihovic S, Schlezinger J, Soshilov A, Steenland K, Steffensen IL, Tryndyak V, White A, Woskie S, Fletcher T, Ahmadi A, Ahmadi N, Benbrahim-Tallaa L, Bijoux W, Chittiboyina S, de Conti A, Facchin C, Madia F, Mattock H, Merdas M, Pasqual E, Suonio E, Viegas S, Zupunski L, Wedekind R, Schubauer-Berigan MK. Zahm S, et al. Among authors: moller p. Lancet Oncol. 2024 Jan;25(1):16-17. doi: 10.1016/S1470-2045(23)00622-8. Epub 2023 Nov 30. Lancet Oncol. 2024. PMID: 38043561 No abstract available.
[Giant cell tumor of bone-an update].
Tschavoll F, Lutteri G, Leinauer B, Mellert K, Möller P, Barth TFE. Tschavoll F, et al. Among authors: moller p. Pathologie (Heidelb). 2023 Dec;44(Suppl 3):215-219. doi: 10.1007/s00292-023-01271-9. Epub 2023 Nov 20. Pathologie (Heidelb). 2023. PMID: 37985483 Review. German.
690 results